ARIAD PHARMACEUTICALS INC SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
ARIAD PHARMACEUTICALS INC reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of $6.15 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2016-11-08
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2016-09-30 was $6.15M, a 60.31% increase year-over-year.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2016-06-30 was $6.63M, a 487.68% increase year-over-year.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2016-03-31 was $5.52M, a 171.64% increase year-over-year.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for the quarter ending 2015-12-31 was $5.91M.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2015 was $12.90M, a 234.59% increase from fiscal 2014.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2014 was $3.86M, a 11.83% increase from fiscal 2013.
- ARIAD PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2013 was $3.45M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 3 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 6 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 9 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|---|---|---|
| 2016-09-30 | $6.15M 10-Q · filed 2016-11-08 | $12.78M derived: sum of 2 quarters · filed 2016-11-08 | $18.29M derived: sum of 3 quarters · filed 2016-11-08 | $24.20M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | $6.63M 10-Q · filed 2016-11-08 | $12.15M derived: sum of 2 quarters · filed 2016-11-08 | $18.06M derived: sum of 3 quarters · filed 2016-11-08 | $21.89M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-03-31 | $5.52M 10-Q · filed 2016-11-08 | $11.43M derived: sum of 2 quarters · filed 2016-11-08 | $15.26M derived: sum of 3 quarters · filed 2016-11-08 | $16.39M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-12-31 | $5.91M derived: 10-K 12 month − 3 quarters · filed 2016-02-29 | $9.75M derived: sum of 2 quarters · filed 2016-02-29 | $10.87M derived: sum of 3 quarters · filed 2016-02-29 | $12.90M 10-K · filed 2016-02-29 |
| 2015-09-30 | $3.83M 10-Q · filed 2015-11-06 | $4.96M derived: sum of 2 quarters · filed 2015-11-06 | $6.99M derived: sum of 3 quarters · filed 2015-11-06 | |
| 2015-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-06 | $3.16M 10-Q · filed 2015-11-06 | ||
| 2015-03-31 | $2.03M 10-Q · filed 2015-11-06 | |||
| 2014-12-31 | $3.86M 10-K · filed 2016-02-29 | |||
| 2014-09-30 | $808.00K 10-Q · filed 2014-11-07 | $1.83M derived: sum of 2 quarters · filed 2014-11-07 | $2.66M derived: sum of 3 quarters · filed 2014-11-07 | |
| 2014-06-30 | $1.02M 10-Q · filed 2014-11-07 | $1.85M derived: sum of 2 quarters · filed 2014-11-07 | ||
| 2014-03-31 | $828.00K 10-Q · filed 2014-11-07 | |||
| 2013-12-31 | $3.45M 10-K · filed 2015-03-02 | |||
| 2013-09-30 | $1.33M 10-Q · filed 2013-11-12 | $2.06M derived: sum of 2 quarters · filed 2013-11-12 | $2.30M derived: sum of 3 quarters · filed 2013-11-12 | |
| 2013-06-30 | $727.00K 10-Q · filed 2013-11-12 | $967.00K derived: sum of 2 quarters · filed 2013-11-12 | ||
| 2013-03-31 | $240.00K 10-Q · filed 2013-11-12 |